Slingshot members are tracking this event:

FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
RHHBY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 11, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Anti-pdl, Mpdl3280a, Nsclc, Programmed Death Ligand-1, Platinum-containing Chemotherapy